Table of Content
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates & Forecast Timeline
1.1.3 Research Scope and Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’S Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 U.S. Patient Engagement Solutions Market Outlook, 2016-2028 (USD Million)
2.2 U.S. Patient Engagement Solutions Market Summary, 2020
Chapter 3 Market Variables, Trends & Scope
3.1 U.S. Patient Engagement Solutions Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Rising Geriatric Population
3.1.3 Increasing Prevalence of Chronic Conditions
3.1.3.1 Neurological disorders
3.1.3.2 Cancer
3.1.3.3 Type 2 diabetes
3.1.4 Favorable Government Initiatives
3.1.5 Increasing Use of Mobile Health
3.1.6 Increasing Investments by Stakeholders
3.1.7 Market Restraint Analysis
3.1.8 Protection of Patient Information
3.1.9 Requirement for Infrastructure
3.2 Penetration & Growth Prospect Mapping
3.3 U.S. Patient Engagement Solutions Market Analysis Tools: Porter’s Five Forces Analysis
3.4 U.S. Patient Engagement Solutions: SWOT Analysis by Factors (Political & Legal, Economic, Social and Technological)
3.5 Target Audience
3.5.1 List of Key Buyers
3.6 Buyer’s Preference Analysis
3.7 Potential Target Audience
3.8 Changing Technology & Their Adoption
3.8.1 Adoption Rate of Changing Technology
3.8.2 Timeline with Major Technology Changes
3.9 Product & Service Analysis
Chapter 4 U.S. Patient Engagement Solutions Market: Covid-19 Impact
4.1 Impact of COVID-19 on the U.S. Patient Engagement Solutions Application Market
4.2 Regulatory/Policy Changes
4.3 Opportunity Analysis
4.3.1 Increasing Government Initiatives
4.4 Strategies Adopted by Market Players
Chapter 5 U.S. Patient Engagement Solutions Market: Delivery Type Estimates & Trend Analysis
5.1 Delivery Type Market Share Analysis, 2020 & 2028
5.2 Delivery Type Dashboard
5.3 Web-based
5.3.1 Web-based market estimates and forecasts, 2016 - 2028 (USD Million)
5.4 Cloud-based
5.4.1 Cloud-based market estimates and forecasts, 2016 - 2028 (USD Million)
5.5 On-premise
5.5.1 On-premise market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 6 U.S. Patient Engagement Solutions Market: Component Estimates & Trend Analysis
6.1 Component Market Share Analysis, 2020 & 2028
6.2 Component Dashboard
6.3 Software
6.3.1 Software market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.2 Standalone Software
6.3.2.1 Standalone software market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.3 Integrated Software
6.3.3.1 Integrated software market estimates and forecasts, 2016 - 2028 (USD Million)
6.4 Hardware
6.4.1 Hardware market estimates and forecasts, 2016 - 2028 (USD Million)
6.5 Services
6.5.1 Services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.2 Consulting
6.5.2.1 Consulting services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.3 Implementation
6.5.3.1 Implementation services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.4 Education
6.5.4.1 Educational services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.5 Other Services
6.5.5.1 Other services market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 7 U.S. Patient Engagement Solutions Market: Application Estimates & Trend Analysis
7.1 Application Market Share Analysis, 2020 & 2028
7.2 Application Dashboard
7.3 Social Management
7.3.1 Social management market estimates and forecasts, 2016 - 2028 (USD Million)
7.4 Health Management
7.4.1 Health management market estimates and forecasts, 2016 - 2028 (USD Million)
7.5 Home Healthcare Management
7.5.1 Home healthcare market estimates and forecasts, 2016 - 2028 (USD Million)
7.6 Financial Health Management
7.6.1 Financial health management market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 8 U.S. Patient Engagement Solutions Market: End-use Estimates & Trend Analysis
8.1 End-Use Market Share Analysis, 2020 & 2028
8.2 End-use Dashboard
8.3 Providers
8.3.1 Providers market estimates and forecasts, 2016 - 2028 (USD Million)
8.4 Payers
8.4.1 Payers market estimates and forecasts, 2016 - 2028 (USD Million)
8.5 Individual Users
8.5.1 Individual users market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 9 U.S. Patient Engagement Solutions Market: Therapeutic Area Estimates & Trend Analysis
9.1 Therapeutic Area Market Share Analysis, 2020 & 2028
9.2 Therapeutic Area Dashboard
9.3 Chronic Diseases
9.3.1 Chronic diseases market estimates and forecasts, 2016 - 2028 (USD Million)
9.3.2 Diabetes
9.3.2.1 Diabetes market estimates and forecasts, 2016 - 2028 (USD Million)
9.3.3 Cardiovascular Diseases
9.3.3.1 Cardiovascular diseases market estimates and forecasts, 2016 - 2028 (USD Million)
9.3.4 Obesity
9.3.4.1 Obesity market estimates and forecasts, 2016 - 2028 (USD Million)
9.4 Women’s Health
9.4.1 Women’s health market estimates and forecasts, 2016 - 2028 (USD Million)
9.5 Mental Health
9.5.1 Mental health market estimates and forecasts, 2016 - 2028 (USD Million)
9.6 Fitness
9.6.1 Fitness market estimates and forecasts, 2016 - 2028 (USD Million)
9.7 Other Therapeutic Areas
9.7.1 Other therapeutic areas market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.2 Company Profiles
10.2.1 Allscripts Healthcare, LLC
10.2.1.1 Company Overview
10.2.1.2 Financial Performance
10.2.1.3 Product Benchmarking
10.2.1.4 Strategic Initiatives
10.2.2 Orion Health
10.2.2.1 Company Overview
10.2.2.2 Financial Performance
10.2.2.3 Product Benchmarking
10.2.2.4 Strategic Initiatives
10.2.3 Cerner Corporation
10.2.3.1 Company Overview
10.2.3.2 Financial Performance
10.2.3.3 Product Benchmarking
10.2.3.4 Strategic Initiatives
10.2.4 McKesson Corporation
10.2.4.1 Company Overview
10.2.4.2 Financial Performance
10.2.4.3 Product Benchmarking
10.2.4.4 Strategic Initiatives
10.2.5 athenahealth, Inc.
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.6 IBM
10.2.6.1 COMPANY Overview
10.2.6.2 Financial Performance
10.2.6.3 Product Benchmarking
10.2.6.4 Strategic Initiatives
10.2.7 Medecision
10.2.7.1 Company Overview
10.2.7.2 Financial Performance
10.2.7.3 Product Benchmarking
10.2.7.4 Strategic Initiatives
10.2.8 GetWellNetwork, Inc.
10.2.8.1 Company Overview
10.2.8.2 Financial Performance
10.2.8.3 Product Benchmarking
10.2.8.4 Strategic Initiatives
10.2.9 MEDHOST
10.2.9.1 Company Overview
10.2.9.2 Financial Performance
10.2.9.3 Product Benchmarking
10.2.9.4 Strategic Initiatives
10.2.10 Lincor
10.2.10.1 Company Overview
10.2.10.2 Financial Performance
10.2.10.3 Product Benchmarking
10.2.10.4 Strategic Initiatives
10.2.11 IQVIA
10.2.11.1 Company Overview
10.2.11.2 Financial Performance
10.2.11.3 Product Benchmarking
10.2.11.4 Strategic Initiatives
10.2.12 Wolters Kluwer N.V.
10.2.12.1 Company Overview
10.2.12.2 Financial Performance
10.2.12.3 Product Benchmarking
10.2.12.4 Strategic Initiatives
10.2.13 Force Therapeutics LLC
10.2.13.1 Company Overview
10.2.13.2 Financial Performance
10.2.13.3 Product Benchmarking
10.2.13.4 Strategic Initiatives
10.2.14 Quil
10.2.14.1 Company Overview
10.2.14.2 Product Benchmarking
10.2.14.3 Strategic Initiatives
10.2.15 Greenway Health, LLC
10.2.15.1 Company Overview
10.2.15.2 Financial Performance
10.2.15.3 Product Benchmarking
10.2.15.4 Strategic Initiatives
10.2.16 Mytonomy
10.2.16.1 Company Overview
10.2.16.2 Financial Performance
10.2.16.3 Product Benchmarking
10.2.16.4 Strategic Initiatives
10.2.17 Klara Technologies, Inc.
10.2.17.1 Company Overview
10.2.17.2 Financial Performance
10.2.17.3 Product Benchmarking
10.2.17.4 Strategic Initiatives
10.2.18 Solutionreach, Inc.
10.2.18.1 Company Overview
10.2.18.2 Financial Performance
10.2.18.3 Product Benchmarking
10.2.18.4 Strategic Initiatives
List of Figures
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 U.S. Patient Engagement Solutions market revenue (USD Million)
Fig. 11 U.S. Patient Engagement Solutions Market Snapshot
Fig. 12 U.S. Patient Engagement Solutions market dynamics
Fig. 13 U.S. Patient Engagement Solutions market driver impact
Fig. 14 U.S. Patient Engagement Solutions market restraint impact
Fig. 15 Penetration & growth prospect mapping
Fig. 16 U.S. Patient engagement solutions Porter’s analysis
Fig. 17 U.S. Patient engagement solutions - SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 18 Parameters considered prior to U.S. Patient engagement solution selection
Fig. 19 Changing method
Fig. 20 Reasons for replacing existing software
Fig. 21 Time frame for EHR implementation
Fig. 22 Buyers’ integration requirement
Fig. 23 Buyers’ deployment preference
Fig. 24 Technology timeline analysis
Fig. 25 Market participants wise pipe analysis with expected launch date
Fig. 26 U.S. patient engagement solutions market: Delivery type movement analysis
Fig. 27 U.S. Patient Engagement Solutions Market: Delivery Type Dashboard
Fig. 28 Web-based market, 2016 - 2028 (USD Million)
Fig. 29 Cloud-based market, 2016 - 2028 (USD Million)
Fig. 30 On-premise market, 2016 - 2028 (USD Million)
Fig. 31 U.S. Patient Engagement Solutions market: Component movement analysis
Fig. 32 U.S. Patient Engagement Solutions Market: Component Dashboard
Fig. 33 Software market, 2016 - 2028 (USD Million)
Fig. 34 Standalone software market, 2016 - 2028 (USD Million)
Fig. 35 Integrated software market, 2016 - 2028 (USD Million)
Fig. 36 Hardware market, 2016 - 2028 (USD Million)
Fig. 37 Services market, 2016 - 2028 (USD Million)
Fig. 38 Consulting services market, 2016 - 2028 (USD Million)
Fig. 39 Implementation services market, 2016 - 2028 (USD Million)
Fig. 40 Educational services market, 2016 - 2028 (USD Million)
Fig. 41 Other services market, 2016 - 2028 (USD Million)
Fig. 42 U.S. Patient Engagement Solutions Market: Application movement analysis
Fig. 43 U.S. Patient Engagement Solutions Application Dashboard
Fig. 44 Social management market, 2016 - 2028 (USD Million)
Fig. 45 Health management market, 2016 - 2028 (USD Million)
Fig. 46 Home healthcare market, 2016 - 2028 (USD Million)
Fig. 47 Financial health management market, 2016 - 2028 (USD Million)
Fig. 48 U.S. Patient Engagement Solutions market: End-use movement analysis
Fig. 49 U.S. Patient Engagement Solutions Market: End-use Dashboard
Fig. 50 Providers market, 2016 - 2028 (USD Million)
Fig. 51 Payers market, 2016 - 2028 (USD Million)
Fig. 52 Individual users market, 2016 - 2028 (USD Million)
Fig. 53 U.S. Patient Engagement Solutions market: Therapeutic area movement analysis
Fig. 54 U.S. Patient Engagement Solutions Market: Therapeutic Area Dashboard
Fig. 55 Chronic diseases market, 2016 - 2028 (USD Million)
Fig. 56 Diabetes market, 2016 - 2028 (USD Million)
Fig. 57 Cardiovascular diseases market, 2016 - 2028 (USD Million)
Fig. 58 Obesity market, 2016 - 2028 (USD Million)
Fig. 59 Women’s health market, 2016 - 2028 (USD Million)
Fig. 60 Mental health market, 2016 - 2028 (USD Million)
Fig. 61 Fitness market, 2016 - 2028 (USD Million)
Fig. 62 Other therapeutic areas market, 2016 - 2028 (USD Million)
Fig. 63 Strategy framework
List of Tables
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America geriatric population (Over 60 Years) (Million) (2014-2024)
Table 4 Total Numbers of Americans Aged 65 and Older with Alzheimer’s Dementia
Table 5 North America diabetes prevalence (national prevalence %), 2013 & 2035
Table 6 Product heat map analysis: Patient Education Solutions
Table 7 U.S. Patient Engagement Solutions Market, by delivery type, 2016 - 2028 (USD Million)
Table 8 U.S. Patient Engagement Solutions Market, by component, 2016 - 2028 (USD Million)
Table 9 U.S. Patient Engagement Solutions Software Market, by component, 2016 - 2028 (USD Million)
Table 10 U.S. Patient Engagement Solutions Market, by services type, 2016 - 2028 (USD Million)
Table 11 U.S. Patient Engagement Solutions Market, by end-use, 2016 - 2028 (USD Million)
Table 12 U.S. Patient Engagement Solutions Market, by application, 2016 - 2028 (USD Million)
Table 13 U.S. Patient Engagement Solutions Market, by therapeutic area, 2016 - 2028 (USD Million)
Table 14 U.S. Patient Engagement Solutions Therapeutic Area Market, by chronic diseases, 2016 - 2028 (USD Million)